|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-4-15
|
|
pubmed:abstractText |
To assess the safety and efficacy of a fixed dose of recombinant activated factor VII (rFVIIa; NovoSeven) in the home setting for mild to moderately severe joint, muscle; and mucocutaneous bleeding episodes in patients with haemophilia A or B with inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0340-6245
|
|
pubmed:author |
pubmed-author:AledortL MLM,
pubmed-author:BeardsleyDD,
pubmed-author:CooperH AHA,
pubmed-author:DavignonGG,
pubmed-author:EwensteinB MBM,
pubmed-author:GilchristG SGS,
pubmed-author:GillJ CJC,
pubmed-author:GladerBB,
pubmed-author:HootsW KWK,
pubmed-author:KiskerC TCT,
pubmed-author:LiuM YMY,
pubmed-author:LusherJ MJM,
pubmed-author:RosenfieldC GCG,
pubmed-author:ShapiroA DAD,
pubmed-author:SmithHH,
pubmed-author:TaftEE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
912-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9869160-Adolescent,
pubmed-meshheading:9869160-Adult,
pubmed-meshheading:9869160-Child,
pubmed-meshheading:9869160-Child, Preschool,
pubmed-meshheading:9869160-Drug Administration Schedule,
pubmed-meshheading:9869160-Factor IX,
pubmed-meshheading:9869160-Factor VIII,
pubmed-meshheading:9869160-Factor VIIa,
pubmed-meshheading:9869160-Female,
pubmed-meshheading:9869160-Hemarthrosis,
pubmed-meshheading:9869160-Hemophilia A,
pubmed-meshheading:9869160-Hemophilia B,
pubmed-meshheading:9869160-Hemorrhage,
pubmed-meshheading:9869160-Hemostatics,
pubmed-meshheading:9869160-Home Nursing,
pubmed-meshheading:9869160-Humans,
pubmed-meshheading:9869160-Isoantibodies,
pubmed-meshheading:9869160-Male,
pubmed-meshheading:9869160-Middle Aged,
pubmed-meshheading:9869160-Recombinant Fusion Proteins,
pubmed-meshheading:9869160-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
|
|
pubmed:affiliation |
Division of Hematology, University of Minnesota Hemophilia Treatment Center, Minneapolis 55455, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase III
|
